SEC Form 4 · accession 0001104659-15-071112
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel D Shoemaker
Officer — Chief Scientific Officer
Period of report
Oct 15, 2015
Accepted (ET)
Oct 16, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 15, 2015 | A | 66,000 | $0.00 | A | 94,428 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Award of Restricted Stock Units that vests with respect to 1/2 of the underlying shares on October 12, 2017 and the remaining 1/2 of the underlying shares on October 12, 2019. This grant is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.